跳至主要内容
临床试验/IRCT138903061138N2
IRCT138903061138N2已完成2 期

Evaluation of Carbamazepine and Oxcarbazepine effect on Tinnitus in patients referred to Amir Almomenin Hospital rasht-iran.

Guilan University of Medical Sciences0 个研究点目标入组 57 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
57

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 65 years(—)
性别
All

入选标准

  • 1-tinnitus history more than 6 months; 2- The patients 21-65 years with nonpulsatile tinnitus.
  • Excllusion crateria:1-pulsatile tinnitus 2-mineare's disease 3-vestibular neurinoma 4-otosclerosis 5-the patients use of hearing-aid 6-pregnancy 7- patients with psychologic disorders need to treatment 8-the nontulerance minimal dose of carbamazepine and oxcarbazepine or hypersensitivity to these drugs 9-recent treatment with anti convulsion drugs 10-OCP consumptions and the drugs interaction with carbamazepine but are necessary to patients 10-patients with severe heart disease(CHF,IHD) 11- appearance severe drug hypersensitivity reaction during of treatment

排除标准

  • 未提供

研究者

发起方
Guilan University of Medical Sciences

相似试验

Effect of Carbamazepine and Oxcarbazepine on Tinnitus | 临床试验